Efficacy of Panchakarma in Hypermelanosis from Chloroquine Side Effect: A Case Report
DOI:
https://doi.org/10.37591/tdd.v4i1.300Abstract
Long-term use of chloroquine can sometimes lead to adverse drug reactions manifesting as hypermelanosis, rashes, itching, rashes, eruption etc. Skin hyperpigmentation is generally of a bluish black or grayish color and irreversible even after discontinuation of the drug. This condition can be conceived according to Ayurveda, Dushivisha (DV)—a poisonous substance which is not fully endowed with the qualities of poison by nature and because of its mild potency; it remains in the body for many years causing various symptoms, one among them being discoloration of skin. A 26-year-old female was suffering from hypermelanosis of the skin had history of taking chloroquine. Punch biopsy skin studied for histopathology showed epidermis with hyperpigmentation of the basal layer and melanophages were scattered along with infiltration by mononuclear cells. The case was treated on the line of treatment of DV. The patient started showing lightening of the pigments after six months and almost complete remission after 12 months of the treatment. This patient presented with the DV effect of chloroquine was administered two relevant procedures from Panchakarma, viz., Vamana and Virechana which eliminated accumulated toxins from the body.
Keywords: Hyperpigmentation, chloroquine, Dushivisha (DV), Panchakarma
Cite this Article
Kumar S, Sharma I, Sharma A. Efficacy of Panchakarma in Hypermelanosis from Chloroquine Side Effect: A Case Report. Trends in Drug Delivery. 2017; 4(1): 4–7p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |